Home›Stocks›CMPR

CMPR — structural market context

Cimpress plc Ordinary Shares (

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 14. Each line shows the earlier value, the later value and their dates.

Price

Close $73.44 (Oct 14) vs $74.71 (Oct 13): −1.70%.

Volume

0.95× its 20-session average (203K) on Oct 14.

Includes pre- and post-market trading.

Short interest

Short interest 2.3M shares (settlement Sep 30) vs 2.3M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 1–Sep 14, published Sep 30): no fails listed.

Previous file (settlements Aug 17–Aug 31, published Sep 16): 3 days with fails, largest 587 shares on Aug 18.

No new publication in this window.

Insider filings (Form 4)

None recorded in this window.

CMPR short interest & days to cover

SHARES SHORT
2.3M
% OF FLOAT
—
DAYS TO COVER
10.7
CHANGE VS PRIOR
+0.3%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (15d ago)

CMPR fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-26 · 50d112$87.88
2026-08-19 · 57d387$89.68
2026-08-18 · 58d587$91.75

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

CMPR insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 6 sales

InsiderTypeSharesValueFiled
Keane Robert S · director, officer: CEO, ChairmanSell (S)5K$436K2026-09-15
Keane Robert S · director, officer: CEO, ChairmanSell (S)179$15K2026-09-15
Keane Robert S · director, officer: CEO, ChairmanSell (S)8K$669K2026-09-15
Keane Robert S · director, officer: CEO, ChairmanSell (S)4K$324K2026-09-15
Keane Robert S · director, officer: CEO, ChairmanSell (S)306$26K2026-09-15

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying CMPR?
In the last 12 months of SEC Form 4 filings, CMPR recorded 0 insider purchases and 6 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell CMPR?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with C

CLF · Cleveland-Cliffs Inc.CAI · Caris Life Sciences, Inc. CommCASY · Casey's General Stores, Inc. CCATX · Perspective Therapeutics, Inc.CBLL · CeriBell, Inc.CHPT · ChargePoint Holdings, Inc.All C →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.